Anda belum login :: 01 Feb 2023 15:41 WIB
Detail
ArtikelCorrelation between Receptor Activator of Nuclear Factor-kb Ligand(RANKL), and Osteoprotegerin (OPG) with Cartilage Degradationin Rheumatoid Arthritis Patients  
Oleh: Hidayat, Rudy ; Isbagio, Harry ; Setyohadi, Bambang ; Setiati, Siti
Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Acta Medica Indonesiana vol. 46 no. 01 (Jan. 2014), page 24-29.
Topik: RANKL; OPG; COMP; reumatoid arthritis.
Fulltext: 24760805.pdf (337.19KB)
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: A02.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelAim: to analyze the correlation between Receptor activator of nuclear factor-?ß ligand (RANKL), Osteoprotegrin (OPG) serum level with cartilage oligomeric matrix protein (COMP) serum level as a marker of cartilage degradation in rheumatoid arthritis patients. Methods: a cross-sectional study was conducted on the subjects who came to the outpatient clinic of rheumatology in Cipto Mangunkusumo Hospital. Patients were diagnosed based on the American College of Rheumatology (ACR) 1987 revised criteria. All numerical data, both primary data and data transformation were not normally distributed, so we did bivariate analysis with Spearman correlation test. Results: we collected the data of 60 RA patients with majority of the subject had active disease activity (78.3%). Methotrexate was the most widely disease modifying anti-rheumatoid drug (DMARD) used, either as a single drug (51.7%) or in combination with another DMARD (25.1%). Bivariate analysis was revealed that RANKL, OPG, and OPG/RANKL serum level have no significantly correlation with COMP serum level (p=0.52; p=0.25; p=0.2, respectively). Conclusion: RANKL and OPG serum level, had no correlation with cartilage degradation in rheumatoid arthritis patients.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.03125 second(s)